These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 30043425)
61. Phase I and pharmacologic study of the combination paclitaxel and carboplatin as first-line chemotherapy in stage III and IV ovarian cancer. Huizing MT; van Warmerdam LJ; Rosing H; Schaefers MC; Lai A; Helmerhorst TJ; Veenhof CH; Birkhofer MJ; Rodenhuis S; Beijnen JH; ten Bokkel Huinink WW J Clin Oncol; 1997 May; 15(5):1953-64. PubMed ID: 9164207 [TBL] [Abstract][Full Text] [Related]
62. Safety evaluation of combination doxorubicin and toceranib phosphate (Palladia®) in tumour bearing dogs: a phase I dose-finding study. Pellin MA; Wouda RM; Robinson K; Tsimbas K; Kurzman ID; Biller BJ; Vail DM Vet Comp Oncol; 2017 Sep; 15(3):919-931. PubMed ID: 27146577 [TBL] [Abstract][Full Text] [Related]
63. Prognostic factors in dogs with urinary bladder carcinoma. Rocha TA; Mauldin GN; Patnaik AK; Bergman PJ J Vet Intern Med; 2000; 14(5):486-90. PubMed ID: 11012109 [TBL] [Abstract][Full Text] [Related]
64. Transient chemotherapy-induced alopecia after successful reversal of 5-fluorouracil myelosuppression and neurotoxicosis in a 9-month-old dog. Immelman LM; Goodman IH; Keller N Aust Vet J; 2022 Jun; 100(6):236-242. PubMed ID: 35243627 [TBL] [Abstract][Full Text] [Related]
65. Evaluation of adjuvant carboplatin chemotherapy in the management of surgically excised anal sac apocrine gland adenocarcinoma in dogs. Wouda RM; Borrego J; Keuler NS; Stein T Vet Comp Oncol; 2016 Mar; 14(1):67-80. PubMed ID: 26811974 [TBL] [Abstract][Full Text] [Related]
66. Evaluation of intracavitary carboplatin chemotherapy for treatment of pleural carcinomatosis in cats: a retrospective study of eight cases. Floch F; Boissy L; Lanore D; Sayag D; Serres F J Feline Med Surg; 2020 Feb; 22(2):84-90. PubMed ID: 30720396 [TBL] [Abstract][Full Text] [Related]
67. Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs. Pritchard C; Al-Nadaf S; Rebhun RB; Willcox JL; Skorupski KA; Lejeune A Vet Comp Oncol; 2023 Dec; 21(4):717-725. PubMed ID: 37705417 [TBL] [Abstract][Full Text] [Related]
68. [Combined palliative hypofractionated radiation and carboplatin chemotherapy of intranasal tumours in dogs]. Schwietzer A; Kessler M; Kandel-Tschiederer B Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012 Oct; 40(5):333-40. PubMed ID: 23076017 [TBL] [Abstract][Full Text] [Related]
69. Nimustine Treatment of 11 Cases of Canine Histiocytic Sarcoma. Tani H; Kurita S; Miyamoto R; Sawada H; Fujiwara-Igarashi A; Michishita M; Azakami D; Hasegawa D; Tamura K; Bonkobara M J Am Anim Hosp Assoc; 2020; 56(3):146. PubMed ID: 32182105 [No Abstract] [Full Text] [Related]
70. 5-Fluorouracil toxicosis in the dog. Dorman DC; Coddington KA; Richardson RC J Vet Intern Med; 1990; 4(5):254-7. PubMed ID: 2262927 [TBL] [Abstract][Full Text] [Related]
71. Successful treatment of 5-fluorouracil toxicosis with hemodialysis. Henry JS; Buoncompagni S; Ross S; Istvan SA; Rizzo K; Cowgill LD; Press SA J Vet Emerg Crit Care (San Antonio); 2023; 33(3):388-392. PubMed ID: 36883466 [TBL] [Abstract][Full Text] [Related]
72. Early tumor response to intraarterial or intravenous administration of carboplatin to treat naturally occurring lower urinary tract carcinoma in dogs. Culp WT; Weisse C; Berent AC; Reetz JA; Krick EL; Jackson DE; Kass PH; Clifford CA; Sorenmo KU J Vet Intern Med; 2015; 29(3):900-7. PubMed ID: 25900646 [TBL] [Abstract][Full Text] [Related]
73. Clinical presentation, treatment and outcome of canine malignant mesothelioma: A retrospective study of 34 cases. Moberg HL; Gramer I; Schofield I; Blackwood L; Killick D; Priestnall SL; Guillén A Vet Comp Oncol; 2022 Mar; 20(1):304-312. PubMed ID: 34647420 [TBL] [Abstract][Full Text] [Related]
74. Suspected Carboplatin Extravasation Reactions in Seven Dogs. Miller KB; Lejeune A; Regan R; Szivek A; Kow K J Am Anim Hosp Assoc; 2018; 54(6):360-367. PubMed ID: 30272477 [TBL] [Abstract][Full Text] [Related]
75. Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer. Waite A; Balkman C; Bailey D; Kiselow M; Flory A; Beaulieu BB; Lewis LD; McEntee M Vet Comp Oncol; 2014 Jun; 12(2):160-8. PubMed ID: 22905693 [TBL] [Abstract][Full Text] [Related]
76. Significant response of pituitary carcinoma to carboplatin, leucovorin and fluorouracil chemotherapy: a pediatric case report and review of the literature. AbdelBaki MS; Waguespack SG; Salceda V; Jones J; Stapleton SL; Baskin DS; Okcu MF J Neurooncol; 2017 Oct; 135(1):213-215. PubMed ID: 28667593 [No Abstract] [Full Text] [Related]
77. Toxicity, outcome, and management of anthracycline overdoses in 16 dogs. Lawson HC; Musser ML; Regan R; Moore AS; Hohenhaus A; Flesner B; Johannes CM J Vet Intern Med; 2022 Jan; 36(1):234-243. PubMed ID: 34825413 [TBL] [Abstract][Full Text] [Related]
78. Serum concentration and safety of intravenous drip versus subcutaneous administration of carboplatin in dogs. Iwano M; Sadahiro K; Maruo T; Kawarai S; Kayanuma H; Orito K J Vet Med Sci; 2021 May; 83(5):775-779. PubMed ID: 33716231 [TBL] [Abstract][Full Text] [Related]
79. Adjuvant post-operative chemotherapy in bitches with mammary cancer. Karayannopoulou M; Kaldrymidou E; Constantinidis TC; Dessiris A J Vet Med A Physiol Pathol Clin Med; 2001 Mar; 48(2):85-96. PubMed ID: 11315572 [TBL] [Abstract][Full Text] [Related]
80. Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma. Musser ML; Johannes CM BMC Vet Res; 2021 Aug; 17(1):269. PubMed ID: 34380474 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]